WA Senator Sponsors Bill to Provide More Oversight for Medical Lab Tests
Thursday, September 15, 2022
Accurate lab tests are crucial for medical treatment, and Congress is considering a measure to provide more oversight.
Sen. Patty Murray, D-Wash., and Sen. Richard Burr, R-N.C., have co-sponsored the Food and Drug Administration Safety and Landmark Advancements Act to better regulate diagnostic clinical tests.
Kristin Anderson, an immunotherapy researcher at the University of Washington and a cancer survivor, said an accurate test was crucial after her breast-cancer diagnosis. A lab test determined she had a specific gene mutation, known as BRCA, which helped tailor her chemotherapy treatment.
"Just knowing those pieces of information was really, really helpful when it came to what medicine I was going to receive," Anderson recounted. "It also really helped inform what kind of surgeries I went through."
Anderson pointed out people with the BRCA mutation have a high risk of recurrence, and so she received a double mastectomy to reduce her chances in the future. Under the measure in Congress, companies would have to register their tests with the FDA and provide performance information. Senate lawmakers approved the bill in June, and Congress is negotiating a final version.
Mark Fleury, policy principal of emerging science for the American Center Action Network, said through COVID-19 tests, most people now have the experience of relying on a lab test for health information. He emphasized laboratory-developed tests are mostly accurate and of high quality.
But he pointed to cases such as the company Theranos and its founder, Elizabeth Holmes, who claimed to develop rapid diagnostic blood testing which was later revealed as a scam. He emphasized without third-party review of such tests, there is a lack of certainty for patients, and he believes the legislation is needed.
"Bring up the oversight system to the modern era," Fleury urged. "Treat it as a diagnostic test rather than as an artificial hip, and ensure that if two tests perform the exact same function, that they've been looked at in the exact same way."
Anderson added her gene-mutation test continues to influence her care because people with the BRCA mutation also are at risk for other types of cancer, such as ovarian cancer.
"There are risk-reducing, preventive surgeries that insurance covers for people who are at high risk like me," Anderson explained. "I was able to get those surgeries because I knew and had the information to ask, and my medical providers had the information to recommend."
A Pew poll released last year finds one in 10 Americans report an inaccurate clinical lab test result.
Support for this reporting was provided by The Pew Charitable Trusts.
get more stories like this via email
The work of some nonprofit organizations has only increased with the pandemic and the needs that have come from it. An author and expert in the field …
By Lourdes Medrano for Yes! Media. Broadcast version by Mark Richardson for Arizona News Connection, reporting for the YES! Media-Public News Service …
Hispanic Heritage Month began in mid-September and runs through Oct. 15, and a financial institution in Washington state is finding unique ways to …
Conservation groups say more needs to be done to protect the natural and cultural resources of Utah's Labyrinth Canyon from off-road vehicles…
Despite being aimed at children in kindergarten through third grade, Florida teachers say what's often referred to as the "Don't Say Gay" law has …
Consumer groups are pressing for legislation to reform the way credit agencies handle errors on credit reports. The calls to amend the Fair Credit …
A relatively small number of so-called "super emitters" are responsible for 40% of the methane emissions in oil and gas hotspots such as California's …
As "Banned Books Week" comes to a close, Connecticut libraries have been celebrating with great fervor - despite numerous book bans and challenges…